Ryan S. Youland

Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas

Bradley J. Kemp, Ian F. Parney, Caterina Giannini, 2018, Journal of Neuro-Oncology.